Blue Jet Healthcare is a 1968-founded specialty pharmaceutical, healthcare ingredient, and intermediate business. On the strength of strategic and early investments in research and development (R&D) and manufacturing infrastructure, it has established a contract development and manufacturing organisation (CDMO) business model with specialised chemistry capabilities in contrast to media intermediates and high-intensity sweeteners.

By June 30, 2023, the business had served over 400 clients in 39 nations. The main divisions of Blue Jet Healthcare’s business are three product categories:

Intermediates in Contrast Media

High-intensity Sweeteners Pharma Intermediates, Active Pharmaceutical Ingredients (APIs), and Pharma Intermediates: As of June 30, 2023, Blue Jet operated three manufacturing facilities in the Indian state of Maharashtra, located in Shahad, Ambernath, and Mahad. These facilities had an annual installed capacity of 200.60 KL, 607.30 KL, and 213.00 KL, respectively.